Shield Therapeutics (STX) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Apr 2023 07:00 AM
RNS
Notice of Results
05 Apr 2023 07:00 AM
RNS
Appointment of Chief Commercial Officer
31 Mar 2023 07:00 AM
RNS
Block Listing 6 Monthly Return
15 Mar 2023 04:35 PM
RNS
Price Monitoring Extension
28 Feb 2023 07:00 AM
RNS
Total Voting Rights Update
17 Feb 2023 11:05 AM
RNS
Second Price Monitoring Extn
17 Feb 2023 11:00 AM
RNS
Price Monitoring Extension
09 Feb 2023 04:40 PM
RNS
Second Price Monitoring Extn
09 Feb 2023 04:35 PM
RNS
Price Monitoring Extension
09 Feb 2023 09:05 AM
RNS
Second Price Monitoring Extn
09 Feb 2023 09:00 AM
RNS
Price Monitoring Extension
09 Feb 2023 07:00 AM
RNS
Full Year Trading Update
23 Jan 2023 11:15 AM
EQS
Hardman & Co Q&A on Shield Therapeutics...
13 Jan 2023 10:30 AM
RNS
Holding(s) in Company
13 Jan 2023 07:15 AM
EQS
Hardman & Co Research: Shield Therapeutics ...
12 Jan 2023 02:40 PM
RNS
Holding(s) in Company
12 Jan 2023 02:15 PM
RNS
Holding(s) in Company
09 Jan 2023 05:10 PM
RNS
Partial AOP Loan Conversion
09 Jan 2023 03:56 PM
RNS
Holding(s) in Company
09 Jan 2023 03:25 PM
RNS
Holding(s) in Company
05 Jan 2023 03:45 PM
RNS
Result of General Meeting & Open Offer
28 Dec 2022 07:00 AM
RNS
PDMR Transaction Notification
28 Dec 2022 07:00 AM
RNS
Total Voting Rights Update
16 Dec 2022 07:00 AM
RNS
Publication of Circular &Notice of General Meeting
13 Dec 2022 03:45 PM
RNS
Successful completion of US$18.5m Equity Fundraise
13 Dec 2022 07:02 AM
RNS
Investor presentation
13 Dec 2022 07:01 AM
RNS
Placing & Subscription to raise approx. US$18m
13 Dec 2022 07:00 AM
RNS
Collaborative Sales Agreement signed with Viatris
31 Oct 2022 07:00 AM
RNS
Republic of Korea update
27 Oct 2022 07:00 AM
RNS
Shelf-life for Accrufer® extended to 48 months
24 Oct 2022 07:00 AM
RNS
Data presented at ACG Annual Scientific Meeting
30 Sep 2022 07:00 AM
RNS
Block Listing 6 Monthly Return
15 Sep 2022 01:52 PM
EQS
Hardman & Co Research on Shield Therapeutic...
14 Sep 2022 02:17 PM
RNS
Holding(s) in Company
08 Sep 2022 07:00 AM
RNS
Half-year Report
01 Sep 2022 02:20 PM
RNS
Holding(s) in Company
01 Sep 2022 07:00 AM
RNS
Launch of new corporate brand and website
31 Aug 2022 02:00 PM
RNS
Total Voting Rights Update
31 Aug 2022 11:00 AM
RNS
Notice of Interim Results
30 Aug 2022 09:30 AM
RNS
Holding(s) in Company
12 Aug 2022 11:45 AM
EQS
Hardman & Co: Q&A on Shield Therapeutic...
09 Aug 2022 04:45 PM
RNS
Grant of share options
01 Aug 2022 07:00 AM
RNS
Completion of Loan Agreement & Partial Conversion
27 Jul 2022 04:20 PM
RNS
Results of 2022 General Meeting
27 Jul 2022 04:15 PM
RNS
Results of 2022 Annual General Meeting
26 Jul 2022 07:15 AM
EQS
Shield Therapeutics (STX): Looking to accelerat...
14 Jul 2022 07:00 AM
RNS
New Drug Submission accepted by Health Canada
08 Jul 2022 07:00 AM
RNS
Notice of General Meeting
30 Jun 2022 04:41 PM
RNS
Second Price Monitoring Extn
30 Jun 2022 04:36 PM
RNS
Price Monitoring Extension

Shield Therapeutics is a pharmaceutical company that develops medicines to treat iron deficiency.

Shield Therapeutics share price is listed on LSE under the ticker STX.

UK 100

Latest directors dealings